Form 8-K - Current report:
SEC Accession No. 0001078782-13-000827
Filing Date
2013-04-26
Accepted
2013-04-26 11:33:39
Documents
2
Period of Report
2013-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K f8k042513_8k.htm 8-K 10532
2 EXHIBIT 99.1 OPTION GRANT FORM f8k042513_ex99z1.htm EX-99.1 56965
  Complete submission text file 0001078782-13-000827.txt   68838
Mailing Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095
Business Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095 801-446-8802
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 13785583
SIC: 2834 Pharmaceutical Preparations